This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignee: Novartis Ag. Active years: 2001-2022.
Location History:
- Lörrach, DE (2001 - 2011)
- Basel, CH (2019 - 2022)
Company Filing History:
Years Active: 2001-2022
Title: Thomas Allmendinger: Innovator in Chemical Synthesis
Introduction
Thomas Allmendinger is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of chemical synthesis, particularly in the development of intermediates and catalysts. With a total of 6 patents to his name, Allmendinger has established himself as a key figure in his industry.
Latest Patents
Among his latest patents, Allmendinger has focused on a new chemical synthesis related to the neprilysin (NEP) inhibitor sacubitril. His inventions include novel intermediates and catalysts that are essential for this synthesis process. These advancements not only enhance the efficiency of the synthesis but also introduce new intermediate compounds that can be utilized in this innovative chemical route.
Career Highlights
Allmendinger is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to apply his expertise in chemical synthesis to real-world applications, contributing to the development of important pharmaceutical products. His innovative approach and dedication to research have made a significant impact in the field.
Collaborations
Throughout his career, Allmendinger has collaborated with several talented professionals, including Thomas Ruch and Paolo Filipponi. These collaborations have fostered a creative environment that encourages the exchange of ideas and the advancement of innovative solutions in chemical synthesis.
Conclusion
In summary, Thomas Allmendinger is a distinguished inventor whose work in chemical synthesis has led to important advancements in the pharmaceutical industry. His contributions, particularly in the development of NEP inhibitors, highlight his role as a key innovator in his field.